KBI Biopharma, Inc. and Selexis SA Expand Executive Leadership Team with the Appointment of Abdelaziz Toumi, Ph.D. as Chief Business Officer
Read MoreWith the ability to express any recombinant protein, including difficult-to-express proteins, Selexis is proud to have partnered with the following companies, and others, supporting the development of innovative therapies across a range of diseases: